New HIV/AIDS Research Has Been Reported by a Researcher at Sao Paulo State University (UNESP) (The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      A new report from Sao Paulo State University (UNESP) discusses the use of prodrugs as a tool to enhance the properties of nucleoside reverse transcriptase inhibitors for the treatment of HIV/AIDS. The researchers highlight the need for better methods to improve patient access and adherence to therapy, as well as long-term treatment outcomes. The review comprehensively describes various strategies to enhance factors such as water solubility, bioavailability, and drug delivery to specific sites/organs. The report also discusses successful examples and key trends in the application of prodrugs for treating HIV/AIDS. [Extracted from the article]
    • Abstract:
      Copyright of AIDS Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)